|
CONDENSED CONSOLIDATING FINANCIAL STATEMENTS Table 3 (Details) (USD $)
In Thousands, unless otherwise specified
|
12 Months Ended |
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
$ 94,468 |
$ 362,500 |
$ 180,582 |
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
(335,660) |
(269,830) |
(208,556) |
| Acquisitions |
(100,690) |
(43,026) |
0 |
| Investment in other long-term assets |
(8,990) |
(3,469) |
(211) |
| Proceeds from sale or disposition of assets |
2,086 |
2,610 |
29,680 |
| Proceeds from insurance recoveries |
0 |
13,500 |
11,382 |
| Investment in subsidiaries |
0 |
0 |
0 |
| Net cash used in investing activities |
(443,254) |
(300,215) |
(167,705) |
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
949,549 |
1,076,406 |
1,608,188 |
| Debt repayments |
(801,950) |
(1,401,354) |
(1,641,119) |
| Senior note offering, net |
0 |
445,431 |
0 |
| Issuance of common units, net of issuance costs |
317,285 |
240,148 |
288,761 |
| General partner contribution |
6,708 |
5,078 |
6,155 |
| Distributions to unitholders and general partner |
(322,046) |
(305,154) |
(263,896) |
| Proceeds from termination of interest rate swaps |
33,433 |
0 |
0 |
| Contributions from (distributions to) affiliates |
0 |
0 |
0 |
| Net intercompany borrowings (repayments) |
0 |
0 |
0 |
| Other, net |
3,742 |
(4,289) |
(761) |
| Net cash provided by (used in) financing activities |
186,721 |
56,266 |
(2,672) |
| Effect of foreign exchange rate changes on cash |
(1,559) |
564 |
6,426 |
| Net increase (decrease) in cash and cash equivalents |
(163,624) |
119,115 |
16,631 |
| Cash and cash equivalents as of the beginning of the period |
181,121 |
62,006 |
45,375 |
| Cash and cash equivalents as of the end of the period |
17,497 |
181,121 |
62,006 |
|
NuStar Energy
|
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
377,469 |
302,373 |
263,017 |
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
0 |
0 |
0 |
| Acquisitions |
0 |
0 |
|
| Investment in other long-term assets |
0 |
0 |
0 |
| Proceeds from sale or disposition of assets |
0 |
0 |
0 |
| Proceeds from insurance recoveries |
|
0 |
0 |
| Investment in subsidiaries |
(374,628) |
(245,604) |
(295,178) |
| Net cash used in investing activities |
(374,628) |
(245,604) |
(295,178) |
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
0 |
0 |
0 |
| Debt repayments |
0 |
0 |
0 |
| Senior note offering, net |
|
0 |
|
| Issuance of common units, net of issuance costs |
317,285 |
240,148 |
288,761 |
| General partner contribution |
6,708 |
5,078 |
6,155 |
| Distributions to unitholders and general partner |
(322,046) |
(305,154) |
(263,896) |
| Proceeds from termination of interest rate swaps |
0 |
|
|
| Contributions from (distributions to) affiliates |
0 |
0 |
0 |
| Net intercompany borrowings (repayments) |
(4,702) |
3,159 |
1,141 |
| Other, net |
0 |
0 |
0 |
| Net cash provided by (used in) financing activities |
(2,755) |
(56,769) |
32,161 |
| Effect of foreign exchange rate changes on cash |
0 |
0 |
0 |
| Net increase (decrease) in cash and cash equivalents |
86 |
0 |
0 |
| Cash and cash equivalents as of the beginning of the period |
53 |
53 |
53 |
| Cash and cash equivalents as of the end of the period |
139 |
53 |
53 |
|
NuStar Logistics
|
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
121,416 |
144,654 |
103,753 |
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
(197,845) |
(109,023) |
(49,800) |
| Acquisitions |
(47,817) |
0 |
|
| Investment in other long-term assets |
0 |
0 |
0 |
| Proceeds from sale or disposition of assets |
63 |
25 |
29,215 |
| Proceeds from insurance recoveries |
|
0 |
0 |
| Investment in subsidiaries |
0 |
0 |
0 |
| Net cash used in investing activities |
(245,599) |
(108,998) |
(20,585) |
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
949,549 |
1,076,406 |
1,608,188 |
| Debt repayments |
(801,950) |
(1,401,354) |
(1,641,119) |
| Senior note offering, net |
|
445,431 |
|
| Issuance of common units, net of issuance costs |
0 |
0 |
0 |
| General partner contribution |
0 |
0 |
0 |
| Distributions to unitholders and general partner |
(322,046) |
(305,154) |
(263,896) |
| Proceeds from termination of interest rate swaps |
33,433 |
|
|
| Contributions from (distributions to) affiliates |
260,028 |
245,604 |
295,178 |
| Net intercompany borrowings (repayments) |
(105,944) |
19,424 |
(80,506) |
| Other, net |
4,705 |
(3,458) |
(1,982) |
| Net cash provided by (used in) financing activities |
17,775 |
76,899 |
(84,137) |
| Effect of foreign exchange rate changes on cash |
(1,233) |
(6,502) |
2,569 |
| Net increase (decrease) in cash and cash equivalents |
(107,641) |
106,053 |
1,600 |
| Cash and cash equivalents as of the beginning of the period |
107,655 |
1,602 |
2 |
| Cash and cash equivalents as of the end of the period |
14 |
107,655 |
1,602 |
|
NuPOP
|
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
59,109 |
30,740 |
70,433 |
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
(8,093) |
(14,621) |
(23,734) |
| Acquisitions |
0 |
0 |
|
| Investment in other long-term assets |
0 |
0 |
0 |
| Proceeds from sale or disposition of assets |
86 |
34 |
108 |
| Proceeds from insurance recoveries |
|
0 |
0 |
| Investment in subsidiaries |
(56,727) |
0 |
0 |
| Net cash used in investing activities |
(64,734) |
(14,587) |
(23,626) |
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
0 |
0 |
0 |
| Debt repayments |
0 |
0 |
0 |
| Senior note offering, net |
|
0 |
|
| Issuance of common units, net of issuance costs |
0 |
0 |
0 |
| General partner contribution |
0 |
0 |
0 |
| Distributions to unitholders and general partner |
0 |
0 |
0 |
| Proceeds from termination of interest rate swaps |
0 |
|
|
| Contributions from (distributions to) affiliates |
56,727 |
0 |
0 |
| Net intercompany borrowings (repayments) |
(51,102) |
(16,133) |
(47,483) |
| Other, net |
0 |
(20) |
20 |
| Net cash provided by (used in) financing activities |
5,625 |
(16,153) |
(47,463) |
| Effect of foreign exchange rate changes on cash |
0 |
0 |
0 |
| Net increase (decrease) in cash and cash equivalents |
0 |
0 |
(656) |
| Cash and cash equivalents as of the beginning of the period |
0 |
0 |
656 |
| Cash and cash equivalents as of the end of the period |
0 |
0 |
0 |
|
Non-Guarantor Subsidiaries (a)
|
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
(84,135) |
189,918 |
32,302 |
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
(129,722) |
(146,186) |
(135,022) |
| Acquisitions |
(52,873) |
(43,026) |
|
| Investment in other long-term assets |
(8,990) |
(3,469) |
(211) |
| Proceeds from sale or disposition of assets |
1,937 |
2,551 |
357 |
| Proceeds from insurance recoveries |
|
13,500 |
11,382 |
| Investment in subsidiaries |
(56,759) |
(25) |
(30) |
| Net cash used in investing activities |
(246,407) |
(176,655) |
(123,524) |
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
0 |
0 |
0 |
| Debt repayments |
0 |
0 |
0 |
| Senior note offering, net |
|
0 |
|
| Issuance of common units, net of issuance costs |
0 |
0 |
0 |
| General partner contribution |
0 |
0 |
0 |
| Distributions to unitholders and general partner |
(32) |
(31) |
(25,027) |
| Proceeds from termination of interest rate swaps |
0 |
|
|
| Contributions from (distributions to) affiliates |
114,053 |
25 |
30 |
| Net intercompany borrowings (repayments) |
161,741 |
(6,450) |
126,848 |
| Other, net |
(963) |
(811) |
1,201 |
| Net cash provided by (used in) financing activities |
274,799 |
(7,267) |
103,052 |
| Effect of foreign exchange rate changes on cash |
(326) |
7,066 |
3,857 |
| Net increase (decrease) in cash and cash equivalents |
(56,069) |
13,062 |
15,687 |
| Cash and cash equivalents as of the beginning of the period |
73,413 |
60,351 |
44,664 |
| Cash and cash equivalents as of the end of the period |
17,344 |
73,413 |
60,351 |
|
Eliminations
|
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
(379,391) |
(305,185) |
(288,923) |
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
0 |
0 |
0 |
| Acquisitions |
0 |
0 |
|
| Investment in other long-term assets |
0 |
0 |
0 |
| Proceeds from sale or disposition of assets |
0 |
0 |
0 |
| Proceeds from insurance recoveries |
|
0 |
0 |
| Investment in subsidiaries |
488,114 |
245,629 |
295,208 |
| Net cash used in investing activities |
488,114 |
245,629 |
295,208 |
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
0 |
0 |
0 |
| Debt repayments |
0 |
0 |
0 |
| Senior note offering, net |
|
0 |
|
| Issuance of common units, net of issuance costs |
0 |
0 |
0 |
| General partner contribution |
0 |
0 |
0 |
| Distributions to unitholders and general partner |
322,078 |
305,185 |
288,923 |
| Proceeds from termination of interest rate swaps |
0 |
|
|
| Contributions from (distributions to) affiliates |
(430,808) |
(245,629) |
(295,208) |
| Net intercompany borrowings (repayments) |
7 |
0 |
0 |
| Other, net |
0 |
0 |
0 |
| Net cash provided by (used in) financing activities |
(108,723) |
59,556 |
(6,285) |
| Effect of foreign exchange rate changes on cash |
0 |
0 |
0 |
| Net increase (decrease) in cash and cash equivalents |
0 |
0 |
0 |
| Cash and cash equivalents as of the beginning of the period |
0 |
0 |
0 |
| Cash and cash equivalents as of the end of the period |
$ 0 |
$ 0 |
$ 0 |